Common Stock - Schedule of Stockholders Equity Activity (Details) - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended | ||||||
---|---|---|---|---|---|---|---|---|---|
May 09, 2025 |
May 07, 2024 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2024 |
Mar. 31, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Dec. 31, 2024 |
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Beginning balance (in shares) | 135,487,595 | 135,487,595 | |||||||
Net assets at beginning of period attributable to common stock | $ 1,898,833,000 | $ 1,910,377,000 | $ 1,998,558,000 | $ 388,119,000 | $ 1,910,377,000 | $ 388,119,000 | $ 388,119,000 | ||
Net investment income (loss) | 39,580,000 | 44,924,000 | 48,677,000 | 49,737,000 | 84,504,000 | 98,414,000 | |||
Net realized gain (loss) from investment transactions | (11,492,000) | 3,452,000 | 250,000 | 1,283,000 | (8,040,000) | 1,533,000 | |||
Net change in unrealized appreciation (depreciation) on investments | (1,930,000) | (23,517,000) | (16,015,000) | (24,800,000) | (25,447,000) | (40,815,000) | |||
Accretion to redemption value of Series A redeemable convertible preferred stock | (4,000) | (5,000) | (4,000) | (5,000) | |||||
Accrual of Series A redeemable convertible preferred stock distributions | (1,687,000) | (1,686,000) | (1,687,000) | (2,197,000) | |||||
Distributions to common stockholders | (44,942,000) | (44,703,000) | (45,004,000) | (11,182,000) | (89,645,000) | (56,186,000) | |||
Issuance of shares in connection with the Merger | 1,594,261,000 | ||||||||
Issuance of common stock, net of issuance costs (in shares) | 110,096,838 | ||||||||
Issuance of common stock, net of issuance costs | 900,000 | $ 0 | 900,000 | ||||||
Repurchases (in shares) | (2,475,427,000) | (2,676,696,000) | (2,475,426) | (2,968,706) | |||||
Repurchases | $ (34,903,490) | $ (38,785,300) | (34,903,000) | (41,170,000) | $ (34,903,000) | (41,170,000) | $ (43,017,000) | ||
Reinvested dividends (in shares) | 1,375,128 | 2,279,074 | |||||||
Reinvestment of common stockholder distributions | $ 9,292,000 | 9,991,000 | $ 9,933,000 | 3,342,000 | $ 19,283,000 | $ 13,275,000 | $ 33,106,000 | ||
Ending balance (in shares) | 134,387,297 | 134,244,259 | 134,387,297 | 134,244,259 | 135,487,595 | ||||
Net assets at end of period attributable to common stock | $ 1,852,747,000 | $ 1,898,833,000 | $ 1,954,438,000 | $ 1,998,558,000 | $ 1,852,747,000 | $ 1,954,438,000 | $ 1,910,377,000 | ||
Common Stock | |||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Beginning balance (in shares) | 136,196,142 | 135,487,595 | 136,335,073 | 26,080,389 | 135,487,595 | 26,080,389 | 26,080,389 | ||
Net assets at beginning of period attributable to common stock | $ 136,000 | $ 135,000 | $ 136,000 | $ 26,000 | $ 135,000 | $ 26,000 | $ 26,000 | ||
Issuance of shares in connection with the Merger (in shares) | 110,033,324 | ||||||||
Issuance of shares in connection with the Merger | $ 110,000 | ||||||||
Issuance of common stock, net of issuance costs (in shares) | 61,058 | ||||||||
Issuance of common stock, net of issuance costs | $ 1,000 | ||||||||
Repurchases (in shares) | (2,475,426) | (2,837,405) | |||||||
Repurchases | $ (2,000) | $ (3,000) | |||||||
Reinvested dividends (in shares) | 666,581 | 708,547 | 685,533 | 221,360 | |||||
Reinvestment of common stockholder distributions | $ 1,000 | $ 1,000 | $ 1,000 | $ 1,000 | |||||
Ending balance (in shares) | 134,387,297 | 136,196,142 | 134,244,259 | 136,335,073 | 134,387,297 | 134,244,259 | 135,487,595 | ||
Net assets at end of period attributable to common stock | $ 135,000 | $ 136,000 | $ 134,000 | $ 136,000 | $ 135,000 | $ 134,000 | $ 135,000 | ||
Additional paid in capital | |||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Net assets at beginning of period attributable to common stock | 2,527,880,000 | 2,517,890,000 | 1,997,825,000 | 400,332,000 | 2,517,890,000 | 400,332,000 | 400,332,000 | ||
Issuance of shares in connection with the Merger | 1,594,151,000 | ||||||||
Issuance of common stock, net of issuance costs | 900,000 | ||||||||
Repurchases | (34,901,000) | (41,167,000) | |||||||
Reinvestment of common stockholder distributions | 9,291,000 | 9,990,000 | 9,932,000 | 3,342,000 | |||||
Net assets at end of period attributable to common stock | 2,502,270,000 | 2,527,880,000 | 1,967,490,000 | 1,997,825,000 | 2,502,270,000 | 1,967,490,000 | 2,517,890,000 | ||
Total distributable earnings (loss) | |||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
Net assets at beginning of period attributable to common stock | (629,183,000) | (607,648,000) | 597,000 | (12,239,000) | (607,648,000) | (12,239,000) | (12,239,000) | ||
Net investment income (loss) | 39,580,000 | 44,924,000 | 48,677,000 | 49,737,000 | |||||
Net realized gain (loss) from investment transactions | (11,492,000) | 3,452,000 | 250,000 | 1,283,000 | |||||
Net change in unrealized appreciation (depreciation) on investments | (1,930,000) | (23,517,000) | (16,015,000) | (24,800,000) | |||||
Accretion to redemption value of Series A redeemable convertible preferred stock | (4,000) | (5,000) | (4,000) | (5,000) | |||||
Accrual of Series A redeemable convertible preferred stock distributions | (1,687,000) | (1,686,000) | (1,687,000) | (2,197,000) | |||||
Distributions to common stockholders | (44,942,000) | (44,703,000) | (45,004,000) | (11,182,000) | |||||
Net assets at end of period attributable to common stock | $ (649,658,000) | $ (629,183,000) | $ (13,186,000) | $ 597,000 | $ (649,658,000) | $ (13,186,000) | $ (607,648,000) |